Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate
Open Access
- 5 October 2010
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (9) , 1400-1406
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 36 references indexed in Scilit:
- Production of hyperpolarized [1,4- 13 C 2 ]malate from [1,4- 13 C 2 ]fumarate is a marker of cell necrosis and treatment response in tumorsProceedings of the National Academy of Sciences, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Imaging in the era of molecular oncologyNature, 2008
- INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicinInvestigational New Drugs, 2007
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinomaCancer, 2000
- Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinomaCancer, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996